ABG-WTT Global Life Science Capital Partners GP Ltd — Q3 2025 13F-HR

← ABG-WTT Global Life Science Capital Partners GP Ltd

Q3 2025 · 13F-HR

ABG-WTT Global Life Science Capital Partners GP Ltdholdings as filed

Filed 2025-11-14 · accession 0001193125-25-283037

$18.7M

Reported value

Positions

2025-09-30

Period end

View analyzed profile →PRO

The Brief · ABG-WTT Global Life Science Capital Partners GP Ltd · Q3 2025

AI · grounded in 13F

ABG-WTT Global Life Science Capital Partners GP Ltd reported no changes to its 13F holdings for 2025-09-30 relative to 2025-06-30.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
15678C102	CBLL	CERIBELL INC	$12.5M	66.9%	1,088,101	Common	SOLE
75340L104	RPID	RAPID MICRO BIOSYSTEMS INC	$6.2M	33.1%	1,848,296	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.